We develop, manufacture and market bone health-related early assessment and monitoring solutions. In particular, we lead the market with advanced ultrasound technology and devices that enable physicians to provide early assessment, diagnosis and monitoring of osteoporosis and to assess bone age. There are already thousands of Sunlight devices in use in clinics, physician offices, research centers, hospitals and pharmacies around the world.
Our Sunlight Omnisense™ line of devices is based on our patented Omnipath™ axial transmission technology, a quantitative ultrasound technology that has been proven to offer high accuracy and patient safety. Measurement using our Omnisense devices is reimbursed in the USA and other countries.
Addressing a Widespread Health Problem – Osteoporosis
Osteoporosis is a progressive systemic skeletal disease that is accepted as a major public health problem, with huge associated cost. Osteoporosis-related fractures increase dramatically with age and they often cause rapid deterioration in health, resulting in death. According to the International Osteoporosis Foundation (IOF), hundreds of millions of people worldwide are affected by osteoporosis – about 80% are women.
Osteoporosis cannot be reversed. However, it can be effectively managed by early diagnosis of bone mass loss and by prevention of further loss. Although early assessment is key, the IOF estimates that more than 70% of the people at risk of osteoporosis have never been diagnosed or screened – signifying a pressing need for easy, cost-effective and safe early assessment tools.
Pioneering Early Assessment of Bone density
As the first – and currently only – devices that enable ultrasound-based, multi-site measurement for early assessment and monitoring of osteoporosis, our Sunlight systems overcome the cost and radiation exposure-related challenges of Dual X-ray Absorption technology (DXA). High accuracy, small size, ease of use, reliability, excellent affordability, and radiation-free operation mean that Sunlight systems can easily and safely be used in any doctor’s office, clinic or retail venue such as pharmacies and annual checkup facilities.
We offer a range of Sunlight Omnisense solutions, all based on our proven Omnipath technology.
Sunlight Omnisense™ 7000 is designed for accurate, quick and patient-friendly assessment and monitoring of osteoporosis.
Sunlight Omnisense™ 8000 offers the same extensive functionality as the 7000 but is portable.
Sunlight MiniOmni™ is the world’s first, proven device specifically designed for early assessment and monitoring of osteoporosis anywhere, anytime. The exceptionally small and affordable unit plugs via USB connectivity into Windows™ XP/7-based notebook or desktop computer.
We also offer unique solutions that cover the pediatric population:
Solid Company with a Strong Growth Path
The Sunlight product line and brand is owned by BeamMed Ltd. – a company wholly focused on bone health. BeamMed was founded in 2004 and is headquartered in Israel. It purchased the Sunlight ultrasound division and IP in 2006, and has since significantly expanded the Sunlight installed base and extended the line with new products. Privately owned, BeamMed is led by a seasoned management team and is backed by strong investment groups, providing a solid financial base for its development road map and global growth plans.